vs

Side-by-side financial comparison of Granite Ridge Resources, Inc. (GRNT) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

Granite Ridge Resources, Inc. is the larger business by last-quarter revenue ($105.5M vs $75.5M, roughly 1.4× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -0.8%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 8.9%).

Granite Ridge Resources, Inc. is an independent upstream energy company focused on the exploration, development, and production of oil, natural gas, and natural gas liquids. It operates low-cost, high-yield onshore hydrocarbon assets across key U.S. basins, primarily serving North American energy markets.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

GRNT vs PBYI — Head-to-Head

Bigger by revenue
GRNT
GRNT
1.4× larger
GRNT
$105.5M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+28.5% gap
PBYI
27.7%
-0.8%
GRNT
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
8.9%
GRNT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GRNT
GRNT
PBYI
PBYI
Revenue
$105.5M
$75.5M
Net Profit
Gross Margin
69.3%
Operating Margin
-34.5%
22.7%
Net Margin
Revenue YoY
-0.8%
27.7%
Net Profit YoY
EPS (diluted)
$-0.19
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GRNT
GRNT
PBYI
PBYI
Q4 25
$105.5M
$75.5M
Q3 25
$112.7M
$54.5M
Q2 25
$109.2M
$52.4M
Q1 25
$122.9M
$46.0M
Q4 24
$106.3M
$59.1M
Q3 24
$94.1M
$80.5M
Q2 24
$90.7M
$47.1M
Q1 24
$89.0M
$43.8M
Net Profit
GRNT
GRNT
PBYI
PBYI
Q4 25
Q3 25
$14.5M
$8.8M
Q2 25
$25.1M
$5.9M
Q1 25
$9.8M
$3.0M
Q4 24
Q3 24
$9.1M
$20.3M
Q2 24
$5.1M
$-4.5M
Q1 24
$16.2M
$-4.8M
Gross Margin
GRNT
GRNT
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
GRNT
GRNT
PBYI
PBYI
Q4 25
-34.5%
22.7%
Q3 25
17.4%
17.6%
Q2 25
19.0%
12.7%
Q1 25
34.6%
8.7%
Q4 24
-6.5%
22.6%
Q3 24
26.2%
27.4%
Q2 24
24.1%
-4.6%
Q1 24
22.0%
-5.3%
Net Margin
GRNT
GRNT
PBYI
PBYI
Q4 25
Q3 25
12.9%
16.2%
Q2 25
23.0%
11.2%
Q1 25
8.0%
6.5%
Q4 24
Q3 24
9.6%
25.2%
Q2 24
5.6%
-9.6%
Q1 24
18.2%
-11.0%
EPS (diluted)
GRNT
GRNT
PBYI
PBYI
Q4 25
$-0.19
$0.26
Q3 25
$0.11
$0.17
Q2 25
$0.19
$0.12
Q1 25
$0.07
$0.06
Q4 24
$-0.09
$0.40
Q3 24
$0.07
$0.41
Q2 24
$0.04
$-0.09
Q1 24
$0.12
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GRNT
GRNT
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$97.5M
Total DebtLower is stronger
$367.8M
$22.7M
Stockholders' EquityBook value
$605.8M
$130.3M
Total Assets
$1.2B
$216.3M
Debt / EquityLower = less leverage
0.61×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GRNT
GRNT
PBYI
PBYI
Q4 25
$97.5M
Q3 25
$94.4M
Q2 25
$96.0M
Q1 25
$93.2M
Q4 24
$101.0M
Q3 24
$96.7M
Q2 24
$96.8M
Q1 24
$107.2M
Total Debt
GRNT
GRNT
PBYI
PBYI
Q4 25
$367.8M
$22.7M
Q3 25
$300.0M
$34.0M
Q2 25
$275.0M
$45.3M
Q1 25
$250.0M
$56.7M
Q4 24
$205.0M
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$137.5M
$102.0M
Stockholders' Equity
GRNT
GRNT
PBYI
PBYI
Q4 25
$605.8M
$130.3M
Q3 25
$643.9M
$115.3M
Q2 25
$642.5M
$104.7M
Q1 25
$631.4M
$97.1M
Q4 24
$635.4M
$92.1M
Q3 24
$660.6M
$71.1M
Q2 24
$665.3M
$48.5M
Q1 24
$674.0M
$51.0M
Total Assets
GRNT
GRNT
PBYI
PBYI
Q4 25
$1.2B
$216.3M
Q3 25
$1.1B
$202.9M
Q2 25
$1.1B
$194.9M
Q1 25
$1.1B
$196.2M
Q4 24
$1.0B
$213.3M
Q3 24
$1.0B
$220.7M
Q2 24
$990.5M
$205.0M
Q1 24
$966.7M
$214.1M
Debt / Equity
GRNT
GRNT
PBYI
PBYI
Q4 25
0.61×
0.17×
Q3 25
0.47×
0.30×
Q2 25
0.43×
0.43×
Q1 25
0.40×
0.58×
Q4 24
0.32×
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
0.20×
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GRNT
GRNT
PBYI
PBYI
Operating Cash FlowLast quarter
$64.5M
$14.4M
Free Cash FlowOCF − Capex
$14.4M
FCF MarginFCF / Revenue
19.1%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GRNT
GRNT
PBYI
PBYI
Q4 25
$64.5M
$14.4M
Q3 25
$77.8M
$9.7M
Q2 25
$78.0M
$14.1M
Q1 25
$76.1M
$3.6M
Q4 24
$68.2M
$15.6M
Q3 24
$74.7M
$11.0M
Q2 24
$64.2M
$1.0M
Q1 24
$68.7M
$11.2M
Free Cash Flow
GRNT
GRNT
PBYI
PBYI
Q4 25
$14.4M
Q3 25
$9.7M
Q2 25
$14.1M
Q1 25
$3.6M
Q4 24
$15.6M
Q3 24
$11.0M
Q2 24
$1.0M
Q1 24
FCF Margin
GRNT
GRNT
PBYI
PBYI
Q4 25
19.1%
Q3 25
17.7%
Q2 25
26.8%
Q1 25
7.7%
Q4 24
26.4%
Q3 24
13.7%
Q2 24
2.1%
Q1 24
Capex Intensity
GRNT
GRNT
PBYI
PBYI
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
GRNT
GRNT
PBYI
PBYI
Q4 25
Q3 25
5.36×
1.10×
Q2 25
3.11×
2.41×
Q1 25
7.75×
1.21×
Q4 24
Q3 24
8.25×
0.54×
Q2 24
12.58×
Q1 24
4.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GRNT
GRNT

Oil And Gas Service$87.6M83%
Natural Gas Storage$17.9M17%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons